The marine brown alga Dictyota pfaffii from Atol das Rocas, in Northeast Brazil is a rich source of dolabellane diterpene, which has the potential to be used in future antiviral drugs by inhibiting reverse transcriptase (RT) of HIV-1. Reexamination of the minor diterpene
[...] Read more.
The marine brown alga
Dictyota pfaffii from Atol das Rocas, in Northeast Brazil is a rich source of dolabellane diterpene, which has the potential to be used in future antiviral drugs by inhibiting reverse transcriptase (RT) of HIV-1. Reexamination of the minor diterpene constituents yielded three new dolabellane diterpenes, (1
R*,2
E,4
R*,7
S,10
S*,11
S*,12
R*)10,18-diacetoxy-7-hydroxy-2,8(17)-dolabelladiene (
1), (1
R*,2
E,4
R*,7
R*,10
S*,11
S*,12
R*)10,18-diacetoxy-7-hydroxy-2,8(17)-dolabelladiene (
2), (1
R*,2
E,4
R*,8
E,10
S*,11
S,12
R*)10,18-diacetoxy-7-hydroxy-2,8-dolabelladiene (
3), termed dolabelladienols A–C (
1–
3) respectively, in addition to the known dolabellane diterpenes (
4–
6). The elucidation of the compounds
1–
3 was assigned by 1D and 2D NMR, MS, optical rotation and molecular modeling, along with the relative configuration of compound
4 and the absolute configuration of
5 by X-ray diffraction. The potent anti-HIV-1 activities displayed by compounds
1 and
2 (IC
50 = 2.9 and 4.1 μM), which were more active than even the known dolabelladienetriol
4, and the low cytotoxic activity against MT-2 lymphocyte tumor cells indicated that these compounds are promising anti-HIV-1 agents.
Full article